254 related articles for article (PubMed ID: 12596654)
1. Some factors affecting prevalence of and immune responses to Schistosoma mansoni in schoolchildren in Gorgora, northwest Ethiopia.
Degu G; Mengistu G; Jones J
Ethiop Med J; 2002 Oct; 40(4):345-52. PubMed ID: 12596654
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
[TBL] [Abstract][Full Text] [Related]
3. Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni.
Vereecken K; Naus CW; Polman K; Scott JT; Diop M; Gryseels B; Kestens L
Trop Med Int Health; 2007 Mar; 12(3):431-44. PubMed ID: 17313515
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of IgG-ELISA for the diagnosis of Schistosoma japonicum in a high prevalence, low intensity endemic area of China.
Lin DD; Xu JM; Zhang YY; Liu YM; Hu F; Xu XL; Li JY; Gao ZL; Wu HW; Kurtis J; Wu GL
Acta Trop; 2008 Aug; 107(2):128-33. PubMed ID: 18589392
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Schistosoma mansoni induced intestinal inflammation by means of eosinophil cationic protein, eosinophil protein X and myeloperoxidase before and after treatment with praziquantel.
Reimert CM; Tukahebwa EM; Kabatereine NB; Dunne DW; Vennervald BJ
Acta Trop; 2008 Mar; 105(3):253-9. PubMed ID: 18177822
[TBL] [Abstract][Full Text] [Related]
6. Effects of single-dose praziquantel on morbidity and mortality resulting from intestinal schistosomiasis.
Kheir MM; Baraka OZ; el-Tom IA; Mukhtar MM; Homieda MM
East Mediterr Health J; 2000; 6(5-6):926-31. PubMed ID: 12197350
[TBL] [Abstract][Full Text] [Related]
7. Sequential analysis of helminth egg output in human stool samples following albendazole and praziquantel administration.
Scherrer AU; Sjöberg MK; Allangba A; Traoré M; Lohourignon LK; Tschannen AB; N'Goran EK; Utzinger J
Acta Trop; 2009 Mar; 109(3):226-31. PubMed ID: 19070583
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia.
Bajiro M; Dana D; Ayana M; Emana D; Mekonnen Z; Zawdie B; Garbi A; Kure A; Zeynudin A
Parasit Vectors; 2016 Oct; 9(1):560. PubMed ID: 27772528
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa.
Saathoff E; Olsen A; Magnussen P; Kvalsvig JD; Becker W; Appleton CC
BMC Infect Dis; 2004 Oct; 4():40. PubMed ID: 15471549
[TBL] [Abstract][Full Text] [Related]
10. Serodiagnosis of Schistosoma mansoni infections in an endemic area of Burkina Faso: performance of several immunological tests with different parasite antigens.
Sorgho H; Bahgat M; Poda JN; Song W; Kirsten C; Doenhoff MJ; Zongo I; Ouédraogo JB; Ruppel A
Acta Trop; 2005 Feb; 93(2):169-80. PubMed ID: 15652331
[TBL] [Abstract][Full Text] [Related]
11. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.
Barakat R; El Morshedy H
Parasitology; 2011 Apr; 138(4):440-6. PubMed ID: 21078223
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an enzyme linked immunosorbent assay (ELISA) using Schistosoma mansoni soluble egg antigen as a diagnostic tool for Schistosoma mansoni infection in Ethiopian schoolchildren.
Eltiro F; Ye-ebiyo Y; Taylor MG
J Trop Med Hyg; 1992 Feb; 95(1):52-6. PubMed ID: 1740820
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and side effects of praziquantel in the treatment for Schistosoma mansoni infection in school children in Senbete Town, northeastern Ethiopia.
Reta B; Erko B
Trop Med Int Health; 2013 Nov; 18(11):1338-43. PubMed ID: 24103059
[TBL] [Abstract][Full Text] [Related]
15. Comparison of immunodiagnosis (ELISA) and stool examination (Kato technique) in the diagnosis of Schistosoma mansoni in Ethiopia.
Jemaneh L
Ethiop Med J; 1993 Jan; 31(1):37-49. PubMed ID: 8436099
[TBL] [Abstract][Full Text] [Related]
16. Performance of IgG avidity in an area endemic for schistosomiasis in Egypt.
Abou-Basha LM; Shehab AY; Abdel-Fattah M; Bassili A
East Mediterr Health J; 2002 Jan; 8(1):172-80. PubMed ID: 15330573
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced, age-related changes in antischistosome antibody responses.
Mutapi F; Hagan P; Woolhouse ME; Mduluza T; Ndhlovu PD
Parasite Immunol; 2003 Feb; 25(2):87-97. PubMed ID: 12791104
[TBL] [Abstract][Full Text] [Related]
18. Cluster analysis of schistosome-specific antibody responses partitions the population into distinct epidemiological groups.
Mutapi F; Mduluza T; Roddam AW
Immunol Lett; 2005 Jan; 96(2):231-40. PubMed ID: 15585328
[TBL] [Abstract][Full Text] [Related]
19. Schistosomiasis mansoni in Burundi: progress in its control since 1985.
Engels D; Ndoricimpa J; Gryseels B
Bull World Health Organ; 1993; 71(2):207-14. PubMed ID: 8490984
[TBL] [Abstract][Full Text] [Related]
20. Age- and sex-related differences in antibody responses against Schistosoma mansoni soluble egg antigen in a cohort of school children in Ethiopia.
Abebe F; Gaarder PI; Petros B; Gundersen SG
APMIS; 2001 Dec; 109(12):816-24. PubMed ID: 11846722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
